Applied Digital Secures MultiBillionDollar Hyperscaler Lease for Polaris Forge 3 Campus Analyst Revises Outlook Shameful UK Welfare Spending on Benefits Over Jobs for Young People Says Alan Milburn Calls for System Reform TVS Motor Set to Replace Adani Enterprises in BSE Sensex 50 Under Index Rejig NASCAR Champion Kyle Busch Dies at 41 Motorsports Industry Faces Potential Impact Bolivias Economic Policy Unrest Escalates Ministers Convoy Ambushed During Roadblock Clearance Huron Consulting Group Faces Pressure as AI Disruption Concerns Weigh on Shares SLE Q1 2026 Earnings EPS Beat Overshadowed by Revenue Concerns and Stock Slide Baker Hughes Q1 2026 Earnings EPS Surges 16 Above Expectations Cerus Corporation CERS Q1 2026 Earnings Narrowing Losses Beat Estimates as Cost Discipline Strengthens AdaptHealth Corp AHCO Q1 2026 Earnings Massive EPS Miss Underlines Operational Challenges TrueBlue Inc Q1 2026 Earnings EPS Surprises Above Estimates Despite Negative Earnings SELLAS Life Sciences Group SLS Gains Ground Biotech Stock Tests Key Resistance After 476 Rally ACCESS Newswire Inc ACCS Gains 125 as Stock Holds Above Key Support Flag Ship Acquisition Corp Rights FSHPR Trading Steady Near 008 Amid Limited Activity Rubrik Inc RBRK Rallies 278 as Momentum Builds Toward Key Resistance Hilton Grand Vacations HGV Edges Lower Amid Broader Market Pressure Truth or Consequences Brewery Tour Featuring MillionBat Migration Draws Tourism Interest SNCY Q1 2026 Earnings EPS Miss Weighs on Market Sentiment as Revenue Figures Remain Undisclosed First Horizon FHN Edges Higher Regional Bank Sentiment Key Levels in Focus The TJX Companies Inc TJX REGN Regeneron Pharmaceuticals reports Q4 2025 EPS beat and 1 percent year over year revenue gain shares edge lower FAF First posts 256 EPS beat but shares fall 215 as investors focus on margin concerns Pixelworks PXLW Stock Is It in Consolidation Phase Pixelworks posts 639 EPS miss on wider losses Public Service Enterprise Group PEG Assessing Earnings Growth Trajectory and Utility Sector Investment Merit IMMX Immix Biopharma posts wider than expected Q4 2025 loss shares edge lower on investor disappointment US Supreme Court Ruling on Executive Unilateral Tariff Authority